# NeoTIL in Advanced Solid Tumors

> **NCT04643574** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Centre Hospitalier Universitaire Vaudois** · enrollment: 42 (estimated)

## Conditions studied

- Solid Tumor, Adult

## Interventions

- **BIOLOGICAL:** NeoTIL
- **DRUG:** Cyclophosphamide
- **DRUG:** Fludarabine
- **DRUG:** Interleukin-2
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT04643574
- **Lead sponsor:** Centre Hospitalier Universitaire Vaudois
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-03-09
- **Primary completion:** 2027-11
- **Final completion:** 2027-11
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2025-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04643574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04643574, "NeoTIL in Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04643574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*